Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporin A in Early Adverse Risk Chronic Lymphocytic Leukemia
2012-002795-13Phase 2Completed
- Sponsor
- University of Birmingham
- Start
- Oct 2012
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cyclosporine in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), sponsored by University of Birmingham. Primary endpoint: Change in proliferation rate of CLL cells. Started Oct 2012; status: completed.
02
Drugs
cyclosporine
03
Conditions
chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Beyond the preview
Go deeper on 2012-002795-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002795-13.